Energy Roundtable
With climate change driving more frequent and severe weather events, the strain on our electric grids has never been greater. In 2023 alone, severe storms, heat waves, and winter freezes left millions without power, costing billions in economic damage and putting lives at risk. And in 2022, an average American experienced 16% more grid…
Latest
Articles
Grid Modernization is Bringing Utilities and Internet Providers to the Table. How Will Collaboration Shape the Grid?
The power grid is in for an exciting era of improvement as it embraces Industry 4.0 and mass digitalization. That doesn’t mean modernization isn’t a tough ride. As the grid grapples with blackouts and shut-offs, one thing is clear: The U.S. needs to modernize its aging grid and embrace technologies that make better use…
Articles
New Energy Infrastructure Vs. Extending Fossil Fuel Plants: How Should the Energy Industry Tackle Aging Power-Generation Assets?
If the expected surge in power demand is anything to go by, the U.S. power grid could be in trouble. Fueled by clean energy projects and a massive shift towards electric vehicles by 2030, it’s clear the grid could face major strain — and even blackouts. Unfortunately, the U.S. has already faced such disasters:…
Articles
Safe Infrastructure Could Put Nuclear Energy on the Fast Track Towards Global Adoption
As the world grapples with the dual challenges of climate change and energy security, nuclear energy emerges as a pivotal solution, sparking a global dialogue on its accelerated adoption and the development of innovative, safe infrastructure. Amidst increasing environmental concerns and the quest for energy independence, countries and companies worldwide are making strategic commitments…
Latest
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
Targeting T Cells Within the Cancer Immunity Cycle
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…
Inside Oncology Drug Development: Overcoming Resistance with Science
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…
